Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

Stock Summary

Top 10 Correlated Stocks

HUM


In the News

07:00 03 Oct 2022 HUM

BlackRock's DeSpirito: Brace For Stubborn Inflation

Inflation is easing, says a top thinker for BlackRock, the world's largest asset manager. But it's not falling to what Americans have grown used to.

01:00 03 Oct 2022 HUM

Humana Proves Vertically Integrated Healthcare Works

Health insurance and wellness provider Humana (NYSE: HUM) stock has been outperforming the benchmark indexes trading up 4.6% for the year

03:51 03 Oct 2022 HUM

Top Health Care Stock Holds Up During Market Downturn, Builds Base

UnitedHealth is building a base as this managed health care stock outperforms the market. The post Top Health Care Stock Holds Up During Market Downturn, Builds Base appeared first on Investor's Business Daily.

10:32 03 Oct 2022 HUM

4 HMO Stocks to Watch Despite Escalating Technology Expenses

A growing customer base and numerous contract wins might drive the Medical-HMO industry. However, high expenses related to technology advancements and a shortage of nurses will dampen margins.

06:00 03 Oct 2022 HUM

Is There More Upside For Humana Stock?

Humana's revenue rising a significant 66% to $89.4 billion over the last twelve months, compared to $53.8 billion in 2017, 2.

08:00 03 Oct 2022 HUM

S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market

S&P 500 giant Eli Lilly leads five medical stocks setting up and showing relative strength in the ongoing bear market. The post S&P 500 Giant Leads 5 Stocks Showing Strength In Bear Market appeared first on Investor's Business Daily.

11:54 03 Oct 2022 HUM

Humana, CVS reportedly eyeing Cano Health acquisition

Yahoo Finance Live anchors Brad Smith and Julie Hyman discuss reports that Humana and CVS are interested in acquiring Cano Health.

10:02 03 Oct 2022 HUM

CANO Stock Moves as Humana, CVS Consider Acquisition

Source: metamorworks / Shutterstock Cano Health (NYSE: CANO ) stock is moving on Friday from reports that Humana (NYSE: HUM ) and CVS (NYSE: CVS ) are considering buying the company. According to insider sources, both companies have expressed interest in buying out CANO and bringing the company into their folds.

09:46 03 Oct 2022 HUM

Cano Health Courts CVS, Humana as Buyout Suitors

Humana could be considering buying Cano Health, according to a Wall Street Journal (WSJ) report citing unnamed sources. This comes amid a broader movement of healthcare giants buying out primary-care providers.

07:08 03 Oct 2022 HUM

Cano Health CEO: Humana is a great partner

Dr. Marlow Hernandez, Cano Health CEO, joins CNBC's Contessa Brewer to discuss the health care space. With CNBC's Melissa Lee and the Fast Money traders, Karen Finerman, Bonawyn Eison, Dan Nathan and Brian Kelly.

Financial details

Company Rating
Strong Buy
Market Cap
61.4B
Income
3.14B
Revenue
89.38B
Book val./share
122.43
Cash/share
143.77
Dividend
3.06
Dividend %
0.63%
Employees
95.5K
Optionable
Yes
Shortable
Yes
Earnings
02 Nov 2022
P/E
19.8
Forward P/E
23.19
PEG
-59.33
P/S
0.69
P/B
3.96
P/C
3.37
P/FCF
22.49
Quick Ratio
1.24
Current Ratio
1.57
Debt / Equity
0.73
LT Debt / Equity
0.73
-
-
EPS (TTM)
24.62
EPS next Y
20.92
EPS next Q
1.17
EPS this Y
-10.52%
EPS next Y
-15.05%
EPS next 5Y
-15.05%
EPS last 5Y
6.11%
Revenue last 5Y
9.09%
Revenue Q/Q
-1.28%
EPS Q/Q
-24.86%
-
-
-
-
SMA20
0.37%
SMA50
1.36%
SMA100
12.18%
Inst Own
92.11%
Inst Trans
1.12%
ROA
7%
ROE
20%
ROC
0.15%
Gross Margin
26%
Oper. Margin
5%
Profit Margin
4%
Payout
12%
Shs Outstand
126.55M
Shs Float
126.23M
-
-
-
-
Target Price
514.83
52W Range
351.2-514.98
52W High
-5.61%
52W Low
+38.23%
RSI
48.29
Rel Volume
1.91
Avg Volume
842.53K
Volume
1.61M
Perf Week
-1.11%
Perf Month
-2.16%
Perf Quarter
5.98%
Perf Half Y
9.92%
-
-
-
-
Beta
0.773871
-
-
Volatility
4.02%, 9.47%
Prev Close
-1.2%
Price
485.19
Change
-1.9%

Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
372.11413.95484.04583.63645.47
Net income per share
16.9412.2420.1925.4722.79
Operating cash flow per share
28.0415.8139.4242.6617.58
Free cash flow per share
24.411.3533.9335.367.35
Cash per share
94.1289.97112.09130.31128.89
Book value per share
68.1173.9189.79103.84124.95
Tangible book value per share
43.8443.7859.1767.7218.43
Share holders equity per share
68.1173.9189.79103.84124.95
Interest debt per share
36.746.9745.7554.94102.15
Market cap
40.79B42.12B46.01B50.65B49.7B
Enterprise value
41.81B46.02B47.85B52.95B59.12B
P/E ratio
16.6625.031715.0416.94
Price to sales ratio
0.760.740.710.660.6
POCF ratio
10.0719.398.718.9821.97
PFCF ratio
11.5726.9910.1210.8352.53
P/B Ratio
4.144.153.823.693.09
PTB ratio
4.144.153.823.693.09
EV to sales
0.780.810.740.690.71
Enterprise value over EBITDA
8.8116.2811.169.513.27
EV to operating cash flow
10.3221.189.069.3926.14
EV to free cash flow
11.8629.4810.5211.3362.5
Earnings yield
0.060.040.060.070.06
Free cash flow yield
0.090.040.10.090.02
Debt to equity
0.480.430.410.440.66
Debt to assets
0.640.60.590.610.64
Net debt to EBITDA
0.211.380.430.412.11
Current ratio
1.381.561.650.990.89
Interest coverage
00009.66
Income quality
1.651.291.951.670.77
Dividend Yield
0.010.010.010.010.01
Payout ratio
0.090.160.110.10.12
Sales general and administrative to revenue
0.120.130.1100
Research and developement to revenue
00000
Intangibles to total assets
0.130.160.140.140.31
Capex to operating cash flow
-0.13-0.28-0.14-0.17-0.58
Capex to revenue
-0.01-0.01-0.01-0.01-0.02
Capex to depreciation
-1.08-1.15-1.28-1.56-1.85
Stock based compensation to revenue
00000
Graham number
161.14142.67201.98243.94253.14
ROIC
00000.11
Return on tangible assets
0.10.080.110.110.1
Graham Net
-21.43-15.43-9.09-23.91-80.1
Working capital
4.84B6.07B7.82B-190M-1.64B
Tangible asset value
6.34B6.02B7.93B8.95B2.37B
Net current asset value
66M1.7B2.85B-8.36B-14.81B
Invested capital
0.510.610.490.510.8
Average receivables
996M1.08B1.1B1.14B1.48B
Average payables
11.91B10.15B11.06B12.16B12.48B
Average inventory
00000
Days sales outstanding
5.86.515.945.387.97
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
62.9656.0761.4567.845.79
Payables turnover
00000
Inventory turnover
00000
ROE
0.250.170.220.250.18
Capex per share
-3.64-4.45-5.49-7.29-10.23

Quarterly Fundamentals Overview

Last date of statement is 2022-06-30 for Q2

Metric History 2021-06-302021-09-302021-12-312022-03-31 2022-06-30
Revenue per share
160.42161.04163.7188.83187.02
Net income per share
4.5711.91-0.117.335.5
Operating cash flow per share
2.822.06-0.752.387.58
Free cash flow per share
0.2419.52-3.630.065.37
Cash per share
130.92140.24128.96141.45143.77
Book value per share
115.34126.52125.03120.68122.43
Tangible book value per share
74.521.9318.4412.2331.43
Share holders equity per share
115.34126.52125.03120.68122.43
Interest debt per share
58.1897.96100.39105.42105.3
Market cap
56.97B50.01B59.66B55.24B59.22B
Enterprise value
61B58.21B69.08B63.67B67.29B
P/E ratio
24.228.17-1.07K14.8521.27
Price to sales ratio
2.762.422.832.32.5
POCF ratio
158.2617.64-621.44182.9161.75
PFCF ratio
1.84K19.93-127.757.89K87.09
P/B Ratio
3.843.083.713.613.82
PTB ratio
3.843.083.713.613.82
EV to sales
2.952.813.282.662.84
Enterprise value over EBITDA
59.8130.32314.0242.1446.96
EV to operating cash flow
169.4620.53-719.62210.8270.17
EV to free cash flow
1.97K23.2-147.939.1K98.96
Earnings yield
0.010.0300.020.01
Free cash flow yield
00.05-0.0100.01
Debt to equity
0.410.710.660.740.73
Debt to assets
0.610.640.640.670.67
Net debt to EBITDA
3.954.2742.855.585.63
Current ratio
0.970.950.8901.57
Interest coverage
0034.59012.03
Income quality
0.611.856.860.321.38
Dividend Yield
00000
Payout ratio
0.150.06-6.50.10.14
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
0.140.30.310.30.25
Capex to operating cash flow
-0.91-0.113.86-0.98-0.29
Capex to revenue
-0.02-0.02-0.02-0.01-0.01
Capex to depreciation
-1.94-1.8-1.91-1.44-1.33
Stock based compensation to revenue
00000
Graham number
108.89184.1517.5141.04123.1
ROIC
000.1100.04
Return on tangible assets
0.020.0500.030.02
Graham Net
-35.35-74.74-80.15-83.74-83.73
Working capital
-497M-749M-1.64B09.85B
Tangible asset value
9.59B2.82B2.37B1.55B3.98B
Net current asset value
-9B-15.04B-14.81B0-4.09B
Invested capital
0.50.770.80.870.85
Average receivables
2.81B2.53B2.49B3.17B3.27B
Average payables
14.31B14.48B14.02B15.24B15.34B
Average inventory
00000
Days sales outstanding
10.638.177.7511.9212.81
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
8.4711.0111.617.557.02
Payables turnover
00000
Inventory turnover
00000
ROE
0.040.0900.060.04
Capex per share
-2.56-2.54-2.88-2.32-2.21

Frequently Asked Questions

What is Humana Inc. stock symbol ?

Humana Inc. is a US stock , located in Louisville of Kentucky and trading under the symbol HUM

Is Humana Inc. buy or a sell ?

27 stock analysts have 27 predictions with a medium analyst target price of $514.85. The lowest prediction is $450 and the highest is $570

What is HUM stock prediction ?

With a median analyst target price of $540.78, 9 stock analysts have made 9 forecasts in last 90 days. $494 is the lowest and $570 is the greatest projection.

What is Humana Inc. stock quote today ?

Humana Inc. stock price is $485.19 today.

Is Humana Inc. stock public?

Yes, Humana Inc. is a publicly traded company.

Something similar

Top Correlated Stocks
Similar Market Cap